8 thoughts on “ Ribozyme - Grinding Tune (CD, Album) ”

1. Indie Recordings was founded in as a side project of Indie Distribution. The label has grown to be one of the leading independent record labels in Scandinavia. Indie Recordings has mainly focused on developing Norwegian acts but, talent knows no borders and lately the label has gone on to sign several foreign successful acts.

   Reply
2. Top tracks. Axis Rotation from Grinding Tune $

   Reply
3. "To thine own self be true", Shakespeare wrote, and since the late 90s Norwegian visionary rock outfit Ribozyme has taken this to heart, even so with their latest brainchild. The aptly named "Argute" is a shrewd take on contemporary hard rock, bringing their signature vocals and harmonies in line with the times- four years after the release of the critically acclaimed "Grinding Tune".

   Reply
4. While still unmistakably Ribozyme, this album goes even further in exploring the harmonic hive mind of Kjartan Ericsson and Bård Bøge whilst providing unfettered rhythmic work from Cato Olaisen - the vocal work is strongly emphasized and adds new depths and subtleties to their trademark sound, occasionally described as a hybrid of Tool, Nine Inch Nails, Oceansize and Alice in Chains.

   Reply
5. Fight The Fight release their follow-up to their well-received and critically acclaimed debut album. A combination of fiery, gritty black metal elements, along with poppy song structures, melodic guitar lines and smashing upbeat drums. 'Deliverance' has the stompy power of read more»Missing: Ribozyme.

   Reply
6. Ribozyme's profile including the latest music, albums, songs, music videos and more updates.

   Reply
7. Explore releases from Ribozyme at Discogs. Shop for Vinyl, CDs and more from Ribozyme at the Discogs Marketplace.

   Reply
8. The album starts with the classic "Korgull The Exterminator". This blazing fast tune perfectly sets the stage for what is to follow, giving samples of nearly everything "Rrroooaaarrr" had to offer(all in the span of just under 5 minutes)/5(17).

   Reply